Investigations into differential glyphosate sensitivity between two horseweed (Conyza canadensis) growth types

Abstract

Horseweed [Conyza canadensis (L.) Cronquist] grows in one of two distinct growth phenotypes, rosette and upright growth types, and they have recently been observed co-occurring in Michigan fields. Previous research found that upright plants from two glyphosate-resistant populations were 3- and 4-fold less sensitive to glyphosate than their rosette siblings. Further experiments were conducted to investigate whether differential glyphosate sensitivity of the growth types was due to glyphosate retention, absorption, or translocation. The total amount of glyphosate retained on the C. canadensis leaf surface was similar for both growth types; however, on a per-weight and per-area bases, the upright growth type retained 21% and 18% less glyphosate, respectively. Glyphosate absorption was up to 85% at 168 h after treatment (HAT), and was not different between the rosette and upright growth types or between the susceptible (S) and resistant (R) biotypes. Additionally, there was no difference in translocation between the two growth types within each biotype at any time point. Interestingly, at 168 HAT, [14C]glyphosate translocation was higher in the S rosette compared with the two growth types from the R biotype; however, the S upright type was similar to both R growth types. Thus, glyphosate resistance in the R biotype may be due to an alternative mechanism rather than impaired translocation, which has been cited as the primary mechanism of glyphosate resistance in C. canadensis. These results suggest that reduced glyphosate retention on a per-weight and per-area bases of the upright growth type may contribute to increased glyphosate tolerance due to a diluted concentration of glyphosate in the plant. However, another factor is likely related to the mechanism of resistance within the R biotype, which is contributing to a 3-fold difference in glyphosate sensitivity between the two growth types, such as alterations in EPSPS gene expression or changes in undescribed metabolism genes.